kafa88 nováček
![nováček nováček](modules/Forums/images/ranks/ranks1.gif)
![](modules/Forums/images/avatars/gallery/blank.gif)
Registrace: 8.7. 2021 Příspěvky: 58
|
Zaslal: pá 17. září, 2021 9:35 Předmět: Marlboro giant seals acquisition of UK inhaler company |
|
|
Marlboro cigarette maker Philip Morris International (PMI) has sealed a £1 billion bid for UK inhaler company Vectura.PMI has said the auction is now backed by nearly three-quarters of Vectura's ownership, more than the 50 percent needed for the takeover.
Moreover, when slotxo you get 3, 4 or 5 adjacent golden reels. You can play the game's specific jackpot and can earn up to 500 times your total bet. We also offer you the Gold Reel function which when activated. It will give you more advantages during slot games such as stack wild symbols,
Vectura manufactures drugs and inhalation devices for the treatment of respiratory diseases such as asthma.Dozens of health groups have called on Vectura to reject the company's bid.In a statement, PMI Chief Executive Jacek Olczak said:
We have achieved a significant milestone in our acquisition of Vectura and are delighted to acquire more than 74% of the company's stake in excess of the 50% required to complete the transaction. our offer without conditions and PMI is a major shareholder
Olczak added he was "excited" about expanding the company's product offering beyond cigarettes and e-cigarette pens. and working with Vectura scientists.PMI recently said it could stop selling cigarettes in the UK within 10 years as it focused on alternatives such as heated tobacco.
'So much trouble'
More than 20 UK, US and European organizations have written to Vectura management urging them to reconsider the merger for ethical and practical reasons.Sarah Woolnough, Chief Executive Officer of Asthma UK and British Lung Foundation, said: “Vectura has sold millions of lung patients.
and prioritizes short-term financial profits over long-term viability of Vectura as a business.She added that the fact that Vectura now owns tobacco could cause "big problems", such as being excluded from research trials. |
|